Detail of 2816 - Hidradenitis Suppurativa

2816 - Hidradenitis Suppurativa ( active )

2816 - Hidradenitis Suppurativa
  • Vertical:
  • 2816 - Hidradenitis Suppurativa
  • Countries:
  • Traffic Types:
  • ------
  • Price Format:
  • cpa ( Base ) , cpa ( Referral Queue )

    Live Geos: https://partners.subjectwell.com/publishers/geos_report/03a11113-e724-4162-a322-37580f82bd6e Ages: 18-70 Gender: All **COPY AND CREATIVE MUST BE SENT TO AFFILIATES@SUBJECTWELL.COM BEORE GOING LIVE** Study Description: This study is testing an investigational oral medication for hidradenitis suppurativa (HS), also known as acne inversa. Participants will receive one daily dose of either the study medication or a placebo for 16 weeks. Total participation will last approximately 6 months and would include 14 doctor’s visits throughout the study. Eligibility for the study will be determined by the study doctor following one or more in-person screening visits to the clinic. Trial-related procedures and study medication will be provided at no cost. Qualifications: - Must have lesions (lumps) present in at least 2 different areas of your body - Cannot be currently receiving treatment for any other active inflammatory conditions